Skip to main content

Table 2 Demographic and clinical characteristics of main study and current study participants

From: DRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcohol

 

Main study

Current study

P values

n = 112

N = 267

Age, mean (SD)

44.1 (7.7)

45.1 (7.1)

0.66

Sex, no (%)

  

0.72

 Male

67 (60)

173 (65)

 

 Female

45 (40)

94 (34)

 

Education no (%)

  

0.24

 8th grade or less

13 (12)

19 (7)

 

 High school diploma

73 (65)

190 (69)

 

 Some college

26 (23)

57 (24)

 

Race/ethnicity no (%)

  

0.26

 Caucasian

17 (15)

21 (8)

 

 African–American

80 (72)

203 (76)

 

 Hispanic

15 (13)

43 (16)

 

Alcohol use, mean (SD)

 Number of standard drinks (past 90 days)

100 (50.1)

190 (100.1)

0.10

 Lifetime

22 (10.5)

23.8 (10.9)

0.24

 AUDIT score

14 (7.5)

16 (8.0)

0.09

Other drugs, mean (SD)

 Number of times cocaine use (past 90 days)

23.5 (16.8)

33.5 (19.8)

0.25

 Number of times marijuana use (past 90 days)

19.3 (12.5)

25.6 (20.9)

0.63

HIV characteristics, mean (SD)

 CD4 count

412.9 (318.4)

441.4 (286.9)

0.73

Viral load no (%)

  

0.16

 Undetectable

45 (40)

128 (48)

 

 50–10,000

39 (35)

80 (30)

 

 10,001–30,000

8 (7)

29 (11)

 

 30,000 or more

20 (18)

29 (11)

 

 Taking ART

76 (68)

216 (81)

0.84

Cognitive measures, mean (SD)

 Executive skills T-scores

50.1 (9.0)

45.2 (10.9)

0.93

 Memory skills (learning) T-scores

45.9 (10.1)

48.2 (9.1)

0.18

 Memory skills (recall) T-scores

48.1 (9.8)

40.0 (10.5)

0.11

 Cognitive flexibility T-scores

40.4 (10.4)

45.7 (10.8)

0.09

 Visual memory T-scores

47.9 (11.9)

43.1 (13.8)

0.09